DE69427537D1 - Antipsychotisches verfahren mit thiadiazol- und oxadiazol-derivaten - Google Patents

Antipsychotisches verfahren mit thiadiazol- und oxadiazol-derivaten

Info

Publication number
DE69427537D1
DE69427537D1 DE69427537T DE69427537T DE69427537D1 DE 69427537 D1 DE69427537 D1 DE 69427537D1 DE 69427537 T DE69427537 T DE 69427537T DE 69427537 T DE69427537 T DE 69427537T DE 69427537 D1 DE69427537 D1 DE 69427537D1
Authority
DE
Germany
Prior art keywords
antipsychotic
thiadiazole
procedure
oxadiazole derivatives
oxadiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69427537T
Other languages
English (en)
Other versions
DE69427537T2 (de
Inventor
Porter Bymaster
E Shannon
Per Sauerberg
H Olesen
Stanley Ward
H Mitch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of DE69427537D1 publication Critical patent/DE69427537D1/de
Application granted granted Critical
Publication of DE69427537T2 publication Critical patent/DE69427537T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
DE69427537T 1993-08-19 1994-08-18 Antipsychotisches verfahren mit thiadiazol- und oxadiazol-derivaten Expired - Fee Related DE69427537T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10928593A 1993-08-19 1993-08-19
PCT/DK1994/000309 WO1995005379A1 (en) 1993-08-19 1994-08-18 Antipsychotic method

Publications (2)

Publication Number Publication Date
DE69427537D1 true DE69427537D1 (de) 2001-07-26
DE69427537T2 DE69427537T2 (de) 2002-04-04

Family

ID=22326851

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69427537T Expired - Fee Related DE69427537T2 (de) 1993-08-19 1994-08-18 Antipsychotisches verfahren mit thiadiazol- und oxadiazol-derivaten

Country Status (23)

Country Link
US (3) US5968926A (de)
EP (1) EP0714394B1 (de)
JP (1) JP3474575B2 (de)
KR (1) KR960703908A (de)
CN (1) CN1040979C (de)
AT (1) ATE202353T1 (de)
CA (1) CA2169838C (de)
CZ (1) CZ42796A3 (de)
DE (1) DE69427537T2 (de)
DK (1) DK0714394T3 (de)
ES (1) ES2160127T3 (de)
FI (1) FI960748A (de)
GR (1) GR3036587T3 (de)
HU (1) HU222116B1 (de)
IL (1) IL110727A (de)
NO (1) NO310597B1 (de)
NZ (2) NZ271313A (de)
PT (1) PT714394E (de)
SG (1) SG55072A1 (de)
TW (1) TW442285B (de)
UA (1) UA43347C2 (de)
WO (1) WO1995005379A1 (de)
ZA (1) ZA946321B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT714394E (pt) * 1993-08-19 2001-12-28 Novo Nordisk As Metodo antipsicotico com derivados de tiadiazol e oxadiazol
US5672709A (en) * 1994-10-24 1997-09-30 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5998404A (en) 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5726193A (en) * 1994-10-31 1998-03-10 Eli Lilly And Company Method for treating anxiety
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
PE17897A1 (es) * 1995-02-17 1997-06-12 Lilly Co Eli Formulacion transdermica en parche del 3-(4-butiltio)-1,2,5-tiadiazol-3-il)-1-azabiciclo (2,2,2) octano
US5763457A (en) * 1995-11-13 1998-06-09 Eli Lilly And Company Method for treating anxiety
US5852037A (en) * 1995-11-13 1998-12-22 Eli Lilly And Company Method for treating anxiety
AU1128297A (en) * 1995-12-06 1997-06-27 Eli Lilly And Company Composition for treating pain
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
US6284771B1 (en) * 1997-04-11 2001-09-04 Eli Lilly And Company Method for treating schizophrenia
EP1007041A4 (de) * 1997-04-11 2001-03-07 Lilly Co Eli Zusammensetzung zur behandlung von schmerzen
US20040023951A1 (en) * 2001-06-18 2004-02-05 Bymaster Franklin Porter Combination therapy for treatment of psychoses
EP2231657A1 (de) * 2007-11-21 2010-09-29 Abbott Laboratories Biarylsubstituierte azabicyclische alkanderivate als modulatoren der aktivität des nicotinischen acetylcholinrezeptors
JP2011520905A (ja) 2008-05-15 2011-07-21 ザ・ユニバーシティ・オブ・トレド 向知性剤としてのムスカリンアゴニスト
US9549928B2 (en) 2011-04-29 2017-01-24 The University Of Toledo Muscarinic agonists as enhancers of cognitive flexibility

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3789039T2 (de) * 1986-06-27 1994-06-09 Beecham Group Plc Verbrückte bicyclische N-heterocyclische Verbindungen.
US4977176A (en) * 1987-01-31 1990-12-11 Sandoz Ltd. Pilocarpine compounds which are used as pharmaceutical agents
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5418240A (en) * 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
PT714394E (pt) * 1993-08-19 2001-12-28 Novo Nordisk As Metodo antipsicotico com derivados de tiadiazol e oxadiazol

Also Published As

Publication number Publication date
AU7490494A (en) 1995-03-14
ZA946321B (en) 1996-02-19
CN1040979C (zh) 1998-12-02
US5677313A (en) 1997-10-14
SG55072A1 (en) 1998-12-21
FI960748A0 (fi) 1996-02-19
CZ42796A3 (en) 1996-12-11
NZ271313A (en) 1999-09-29
UA43347C2 (uk) 2001-12-17
KR960703908A (ko) 1996-08-31
CA2169838C (en) 2002-06-11
GR3036587T3 (en) 2001-12-31
AU697529B2 (en) 1998-10-08
ATE202353T1 (de) 2001-07-15
NZ336596A (en) 2001-02-23
EP0714394B1 (de) 2001-06-20
EP0714394A1 (de) 1996-06-05
PT714394E (pt) 2001-12-28
US5968926A (en) 1999-10-19
DE69427537T2 (de) 2002-04-04
HUT73854A (en) 1996-09-30
JPH09501659A (ja) 1997-02-18
IL110727A (en) 1998-08-16
NO310597B1 (no) 2001-07-30
FI960748A (fi) 1996-04-18
HU9600363D0 (en) 1996-04-29
TW442285B (en) 2001-06-23
IL110727A0 (en) 1994-11-11
CA2169838A1 (en) 1995-02-23
DK0714394T3 (da) 2001-10-01
NO960620L (no) 1996-04-18
JP3474575B2 (ja) 2003-12-08
CN1133044A (zh) 1996-10-09
ES2160127T3 (es) 2001-11-01
US5679686A (en) 1997-10-21
WO1995005379A1 (en) 1995-02-23
HU222116B1 (hu) 2003-04-28
NO960620D0 (no) 1996-02-16

Similar Documents

Publication Publication Date Title
DE69427537T2 (de) Antipsychotisches verfahren mit thiadiazol- und oxadiazol-derivaten
FI20050461A (fi) Antipsykoottinen käyttö
DE69214121D1 (de) Verfahren zur Herstellung von Intraokularlinsen
NO953443D0 (no) Fremgangsmåte for behandling av fast avfall
FI953899A (fi) Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi
NO942906L (no) Fremgangsmåte for oksydasjon av natriumsulfid
NO892963L (no) Fremgangsmaate for fjernelse av hydrogensulfid med spesielle jernoksyder.
FI943702A0 (fi) Menetelmä jäterikkihapon käsittelemiseksi
DE69419598T2 (de) Abstichverfahren für hochofen
FI933624A0 (fi) Apparat foer pappers- och kartongmaskin samt dess anvaendning
DE69408255T2 (de) Startschaltung für induktive oder kapazitive Vorschaltgeräte
FI892051A (fi) Foerfarande foer framstaellning av 5-klor-3-klorsulfonyl-2-tiofencarbonsyraestrar.
DK0517787T3 (da) Fremgangsmåde til behandling af terapiresistent skizofreni med amperozide
KR940019098U (ko) 타이어 가류기의 생타이어 자동 공급 장치
DE69102722D1 (de) Verfahren zur Erzeugung von Roheisen.
FI931153A0 (fi) Anordning foer uppvaermning av stenmaterial

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ELI LILLY AND CO., INDIANAPOLIS, IND., US

8328 Change in the person/name/address of the agent

Representative=s name: SPOTT, WEINMILLER & BOEHM, 80336 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8339 Ceased/non-payment of the annual fee